Chemistry and immunomodulatory activity of frankincense oil

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 58, Issue 3-4, 2003, Pages 230-238

  Mikhaeil, Botros R ^a   Maatooq, Galal T ^a   Badria, Farid A ^a   Amer, Mohamed M A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Frankincense Essential Oil; Immunomodulatory Activity

Indexed keywords

BOSWELLIA SACRA; DUVA;

EID: 0037351055     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2003-3-416     Document Type: Article

References (36)

1. Abdel wahab S. M., Aboutabl E. A., Elzalabani S. M., Fouad H. A., De Pooter H. L., and El Fallaha B. (1987), The essential oil of olibanum. Planta Med. 53, 382-384.
2. Adams R. P. (1989), Identification of Essential Oils by Ion Trap Mass Spectroscopy. Academic Press Inc, San Diego, California.
3. Adams R. P. (1995), Identification of Essential Oil Components by Gas Chromatography Mass Spectroscopy. Allured Publ. Corp., Wheaton, Illinois.
4. Ammar N., Founier G., and El-Deeb S. (1994), The volatile constituents of Boswellia sacra: Frankincense. J. Drug Res.-Cairo 21, 55-58.
5. Ammon, H. P. T., Singh T., and Safayhi H. (1991), Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med. 57, 203-207.
6. Boyum A. (1976), Isolation of lymphocytes, granulocytes, and macrophages. Scand. J. Immunol. Suppl. 5, 9-15.
7. British Pharmacopeia (1998), © Copyright Crown Publishing, London, Vol. II, pp. A138, A139, A171-A173.
8. Dietrich K. (1900), Analyse der Harze, Balsame und Gummiharze neben ihrer Chemie und Pharmacognosie, Springer Publ., Berlin, p. 262.
9. Eklund A. M., Berg J. E., and Wahlberg I. (1992), Tobacco chemistry. 73; 4,6,8-trihydroxy-11-capnosene-2,10-dione, a new cembrane-derived bicyclic diterpenoid from tobacco. Acta Chem. Scand. 46, 367-371.
10. th Edition. WB Saunders Company Ltd., London, p. 289.
11. Gangwal M. L., and Vardhan D. K. (1995), Antifungal studies of volatile constituents of Boswellia serrata. Asian J. Chem. 7, 675-678.
12. Guenther E. (1972), The Essential Oils. Vol. IV, Robert E. Krieger Publ. Co., New York, pp. 352-356.
13. Gupta I., Parihar A., Malhotra P., Singh G. B., Ludtke R., Safayhi H., and Ammon H. P. (1997), Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 2, 37-43.
14. Gupta I., Gupta V., Parihar A., Gupta S., Ludtke R., Safayhi H., and Ammon H. P. (1998), Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 3, 511-514.
15. Hayashi S., Amemori H., Kameoka H., and Hanafusa M. (1998), Comparison of volatile components from olibanum from various countries. J. Ess. Oil Res. 10, 25-30.
16. Lawless J. (1996), The Illustrated Encyclopaedia of Essential Oils, Element Books, London, p. 97.
17. nd Ed., John Wiley and Sons, New York, pp. 389-391.
18. Maria L. B., and Stephen H. (1997), A preliminary study of the effect of essential oils on skeletal and smooth muscles in vitro. J. Ethnopharmacol. 58, 183-187.
19. Maupetit P. (1984/1985), New constituents in olibanum resinoid and essential oils. Perfumer and Flavorist 9, 19-20, 22, 24-26, 28, 30, 32-34, 36-37.
20. Nores M. M., Courrèges M., Benencia F., and Coulombie F. C. (1997), Immunomodulatory activities of Cedrela lilloi and Trichilia elegans leaf extracts. J. Ethnopharmacol. 55, 99-106.
21. Obermann H. (1978), Monoterpensäuren als Spurenkomponenten in Olibanumöl. Dragoco Rep. 3, 55-58.
22. Ohloff G. (1994), Scent and Fragrances (translated by Wilhelm Pickenhagen and Brian M. Lawrence). Springer Publ., Berlin, Heidelberg, p. 188.
23. Puri A., Saxena R., Saxena R. P., and Saxena K. C. (1993), Immunostimulant agents from Andrographis paniculata. J. Nat. Prod. 56, 995-999.
24. Rashid M. A., Gustafson K. R., and Boyd M. R. (2000), HIV-Inhibitory cembrane derivatives from a Philippines collection of the soft coral Lobophytum sp. J. Nat. Prod. 63, 531-533.
25. Ryman D. (1997), Aromatherapy, the Encyclopaedia of Plants and Oils. Judy Piatkus Publishers Ltd., London, pp. 101-102.
26. Safayhi H., Mack T., Sabieraj J., Anazodo M. I., Subramanian L. R., and Ammon H. P. T. (1992), Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxy-genase. J. Pharmacol. Exp. Therap. 261, 1143-1146.
27. Safayhi H., Sailer E. R., and Ammon H. P. T. (1995), Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-Boswellic acid. Mol. Pharmacol. 47, 1212-1216.
28. Sairam M., Sharma G. I., Kumar D., and Selvamurthy W. (1997), Immunomodulatory effects of NIM-76, a volatile fraction from Neem oil. J. Ethnopharmacol. 55, 133-139.
29. Sharma M.L., Khajuria A., Kaul A., Singh S., Singh G. B., and Atal C. K. (1988), Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration. Agents Actions 24, 161-164.
30. Singh G. B., and Atal C. K. (1986), Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 18, 407-412.
31. th edition. Appleton Lange Norwalk, Connecticut, Los Atlos, California, pp. 285-286.
32. Strappaghetti G., Corsano S., Craveiro A., and Proietti G. (1982); Constituents of essential oil of Boswellia frereana. Phytochemistry 21, 2114-2115.
33. Tschrich A., and Stock E. (1935), Die Harze, Gebrüder Bornträger, Berlin, p. 239.
34. Verghese J. (1988), Olibanum in focus. Perfumer and Flavorist 13, 2-11.
35. th Edition. J. & A. Churchill Ltd, London, pp. 500-501.
36. Yates R. L., and Wenninger J. A. (1970), Constituents of olibanum oil: Sesquiterpene hydrocarbons. J. Assoc. Anal. Chem. 53, 941-948.